Social Deprivation and Pregnancy

April 14, 2017 updated by: University Hospital, Clermont-Ferrand

Social deprivation during pregnancy is associated to adverse perinatal outcomes. However, prenatal screening of social deprivation by reliable measurement is not performed. Prevalence of social deprivation is yet underestimated during pregnancy and vulnerable women are not being provided optimal prenatal care.

Our aim is to validate EPICES score during pregnancy.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

The process of deprivation was defined first by J. Wrezinski and P. Townsend who also reported that deprivation is the main cause of inequalities in health. Several studies have already shown an association between socioeconomic deprivation and adverse birth outcomes. EPICES score is the only one that measure individual deprivation. The EPICES score should be therefore included systematically in standard follow-up of pregnant women.

Descriptive analysis will assess women's characteristics and prevalence of social deprivation. Two groups of women will be compared deprived women and non-deprived women.

Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression.

Study Type

Observational

Enrollment (Anticipated)

615

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Clermont-Ferrand, France, 63003
        • CHU Clermont-Ferrand

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

pregnant women

Description

Inclusion Criteria:

  • more than 18 years old
  • delivery at 2 maternity hospitals of Clermont-Ferrand area
  • fluent command of spoken and written French

Exclusion Criteria:

  • Terminations of pregnancy
  • protected women

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
deprived women
Two groups of women will be compared deprived women and non-deprived women
Other: Epices score
Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression
non-deprived women
Two groups of women will be compared deprived women and non-deprived women
Other: Epices score
Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Epices score distribution
Time Frame: at day 1
Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression
at day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse perinatal outcomes
Time Frame: at day 1
Association between EPICES score and the adverse perinatal outcomes will be assessed by quantile regression
at day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Clermont-Ferrand

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 1, 2017

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

May 1, 2018

Study Registration Dates

First Submitted

April 14, 2017

First Submitted That Met QC Criteria

April 14, 2017

First Posted (Actual)

April 20, 2017

Study Record Updates

Last Update Posted (Actual)

April 20, 2017

Last Update Submitted That Met QC Criteria

April 14, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CHU-319
  • 2016-A02076-45 (Other Identifier: 2016-A02076-45)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gestational Diabetes

Clinical Trials on Epices score

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe